Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small molecules targeting protein–protein interactions for cancer therapy
Defa Wu, Yang Li, Lang Zheng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4060-4088
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 173
Evolution of chemistry and selection technology for DNA-encoded library
Peixiang Ma, Shuning Zhang, Qianping Huang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 492-516
Open Access | Times Cited: 27
Development of covalent inhibitors: Principle, design, and application in cancer
Lang Zheng, Yang Li, Defa Wu, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 26
Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges
Zhenwei Zhang, Linghui Hou, Dan Liu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2378-2401
Open Access | Times Cited: 9
Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy
Jing Ye, Jin Zhang, Yanghui Zhu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4688-4714
Open Access | Times Cited: 22
Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects
Xinqi Liang, Ruixian Chen, Chengdi Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 15968-15995
Closed Access | Times Cited: 7
Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling
Yibin Lin, Xiaohong Chen, Linping Lin, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing
Wenkang Fu, Lin Yan-yan, Mingzhen Bai, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3931-3948
Open Access | Times Cited: 4
Salicylaldehyde Benzoylhydrazones with Anticancer Activity and Selectivity: Design, Synthesis, and In Vitro Evaluation
Boryana Nikolova-Mladenova, Rositsa Mihaylova, Mariyana Atanasova, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1015-1015
Open Access
Design, synthesis, and biological evaluation of novel and highly potent peptides targeting syntenin
Yang Zhou, Yuting Wang, Juanjuan Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117446-117446
Closed Access
Targeting mRNA export complex macromolecules THO subunits (Thoc2 and Thoc5) for somatic cell reprograming
Abdur Rehman, Haixin Wang, Chenchen Li, et al.
International Journal of Biological Macromolecules (2025), pp. 142072-142072
Closed Access
The value of coimmunoprecipitation (Co-IP) assays in drug discovery
Zhongtian Cai, Danni Wang, Zekun Li, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-14
Closed Access
Optimization of antimicrobial peptide Smp43 as novel inhibitors of Cancer
Yu Zhou, Dan Han, Kai Zhang, et al.
Bioorganic Chemistry (2025), pp. 108561-108561
Closed Access
Exploring the landscape of post-translational modification in drug discovery
Yuhao Cao, Tianyi Yu, Zhiguang Zhu, et al.
Pharmacology & Therapeutics (2024) Vol. 265, pp. 108749-108749
Closed Access | Times Cited: 3
Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy
Chengyong Wu, Lele Zhang, Zhilan Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116649-116649
Closed Access | Times Cited: 2
An update on small molecule compounds targeting synthetic lethality for cancer therapy
Jiaxiang Luo, Yang Li, Yiwen Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116804-116804
Closed Access | Times Cited: 2
Phase separation of Nur77 mediates XS561-induced apoptosis by promoting the formation of Nur77/Bcl-2 condensates
Xiaohong Chen, Meichun Gao, Yongzhen Xia, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1204-1221
Open Access | Times Cited: 4
Development and therapeutic perspectives of CXCR4 antagonists for disease therapy
Jun Yang, Erkang Tian, Li Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116594-116594
Closed Access | Times Cited: 1
Finding the partner: FRET and beyond
Meghna Sarkar, Reshma Raj R, Tessy Thomas Maliekal
Experimental Cell Research (2024) Vol. 441, Iss. 2, pp. 114166-114166
Closed Access | Times Cited: 1
Analysis of Protein-Protein and Protein-Membrane Interactions by Isotope-Edited Infrared Spectroscopy
Suren A. Tatulian
Physical Chemistry Chemical Physics (2024) Vol. 26, Iss. 33, pp. 21930-21953
Open Access | Times Cited: 1
Discovering new mode‐of‐action pesticide leads inhibiting protein–protein interactions: example targeting plant O‐acetylserine sulfhydrylase
Rotem Shelly Ben‐Shushan, Elad Cohen, Noam Ben‐Naim, et al.
Pest Management Science (2024) Vol. 80, Iss. 12, pp. 6424-6436
Open Access | Times Cited: 1
Design, synthesis, and evaluation of dual son of sevenless 1 (SOS1) and epidermal growth factor receptor (EGFR) inhibitors for the treatment of cancers
Yi Zeng, Chenyang Huang, Qiangqiang Hou, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107833-107833
Closed Access | Times Cited: 1
Acquired resistance to tyrosine kinase targeted therapy: mechanism and tackling strategies
Defa Wu, Qian Sun, Hongjun Tang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101176-101176
Closed Access | Times Cited: 1
Innovative design and potential applications of covalent strategy in drug discovery
Tianxi Tang, Jiaxiang Luo, Dan Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117202-117202
Closed Access | Times Cited: 1
Pesticide chemical leads inhibiting protein-protein interactions
Rotem Shelly Ben Shushan, Elad Cohen, Noam Ben Naim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top